Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Patrick Wilkinson

1PUBLICATIONS

30CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Jun 15, 2022

Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine.

Mathieu Gigoux, Morten O Holmström, Roberta Zappasodi

Pageof 1

Frequent Collaborators

1 joint publications

Mathieu Gigoux

1 joint publications

Morten O Holmström

1 joint publications

Roberta Zappasodi

1 joint publications

Joseph J Park

1 joint publications

Cansu Cimen Bozkus

1 joint publications

Levi M B Mangarin

1 joint publications

David Redmond

1 joint publications

Mariam M George

1 joint publications

Arnab Ghosh

1 joint publications

Zaki Molvi

Frequent Collaborators

1 joint publications

Mathieu Gigoux

1 joint publications

Morten O Holmström

1 joint publications

Roberta Zappasodi

1 joint publications

Joseph J Park

Top Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

See more related videos

Top Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

See more related videos